Logo image of HMSB.DE

HENNES & MAURITZ AB-B SHS (HMSB.DE) Stock Fundamental Analysis

FRA:HMSB - Deutsche Boerse Ag - SE0000106270 - Common Stock - Currency: EUR

12.845  +0.02 (+0.16%)

Fundamental Rating

5

Taking everything into account, HMSB scores 5 out of 10 in our fundamental rating. HMSB was compared to 51 industry peers in the Specialty Retail industry. While HMSB belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. HMSB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

HMSB had positive earnings in the past year.
In the past year HMSB had a positive cash flow from operations.
In the past 5 years HMSB has always been profitable.
HMSB had a positive operating cash flow in each of the past 5 years.
HMSB.DE Yearly Net Income VS EBIT VS OCF VS FCFHMSB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

With an excellent Return On Assets value of 6.18%, HMSB belongs to the best of the industry, outperforming 80.39% of the companies in the same industry.
The Return On Equity of HMSB (23.89%) is better than 88.24% of its industry peers.
HMSB has a better Return On Invested Capital (10.59%) than 80.39% of its industry peers.
HMSB had an Average Return On Invested Capital over the past 3 years of 7.98%. This is in line with the industry average of 9.50%.
The 3 year average ROIC (7.98%) for HMSB is below the current ROIC(10.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.18%
ROE 23.89%
ROIC 10.59%
ROA(3y)4.41%
ROA(5y)4.01%
ROE(3y)16.88%
ROE(5y)14.25%
ROIC(3y)7.98%
ROIC(5y)6.98%
HMSB.DE Yearly ROA, ROE, ROICHMSB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

HMSB's Profit Margin of 4.66% is fine compared to the rest of the industry. HMSB outperforms 78.43% of its industry peers.
HMSB's Profit Margin has declined in the last couple of years.
HMSB's Operating Margin of 7.17% is fine compared to the rest of the industry. HMSB outperforms 76.47% of its industry peers.
HMSB's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 52.87%, HMSB belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
HMSB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.17%
PM (TTM) 4.66%
GM 52.87%
OM growth 3Y-0.56%
OM growth 5Y0.23%
PM growth 3Y-3.61%
PM growth 5Y-3.01%
GM growth 3Y0.42%
GM growth 5Y0.31%
HMSB.DE Yearly Profit, Operating, Gross MarginsHMSB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HMSB is creating value.
Compared to 1 year ago, HMSB has less shares outstanding
The number of shares outstanding for HMSB has been reduced compared to 5 years ago.
Compared to 1 year ago, HMSB has an improved debt to assets ratio.
HMSB.DE Yearly Shares OutstandingHMSB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
HMSB.DE Yearly Total Debt VS Total AssetsHMSB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

HMSB has a debt to FCF ratio of 3.87. This is a good value and a sign of high solvency as HMSB would need 3.87 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.87, HMSB is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 1.40 is on the high side and indicates that HMSB has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.40, HMSB is doing worse than 78.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF 3.87
Altman-Z N/A
ROIC/WACC2.01
WACC5.26%
HMSB.DE Yearly LT Debt VS Equity VS FCFHMSB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.15 indicates that HMSB should not have too much problems paying its short term obligations.
HMSB has a Current ratio (1.15) which is comparable to the rest of the industry.
HMSB has a Quick Ratio of 1.15. This is a bad value and indicates that HMSB is not financially healthy enough and could expect problems in meeting its short term obligations.
HMSB has a Quick ratio (0.51) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.51
HMSB.DE Yearly Current Assets VS Current LiabilitesHMSB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.34% over the past year.
The Earnings Per Share has been decreasing by -2.32% on average over the past years.
HMSB shows a small growth in Revenue. In the last year, the Revenue has grown by 0.56%.
Measured over the past years, HMSB shows a small growth in Revenue. The Revenue has been growing by 0.15% on average per year.
EPS 1Y (TTM)18.34%
EPS 3Y2.83%
EPS 5Y-2.32%
EPS Q2Q%-50.67%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y5.63%
Revenue growth 5Y0.15%
Sales Q2Q%3.1%

3.2 Future

The Earnings Per Share is expected to grow by 6.69% on average over the next years.
The Revenue is expected to grow by 1.02% on average over the next years.
EPS Next Y7.38%
EPS Next 2Y8.98%
EPS Next 3Y8.11%
EPS Next 5Y6.69%
Revenue Next Year0.16%
Revenue Next 2Y1.28%
Revenue Next 3Y1.81%
Revenue Next 5Y1.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HMSB.DE Yearly Revenue VS EstimatesHMSB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B 200B 250B
HMSB.DE Yearly EPS VS EstimatesHMSB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.39 indicates a rather expensive valuation of HMSB.
Based on the Price/Earnings ratio, HMSB is valued a bit cheaper than 72.55% of the companies in the same industry.
When comparing the Price/Earnings ratio of HMSB to the average of the S&P500 Index (25.82), we can say HMSB is valued slightly cheaper.
HMSB is valuated correctly with a Price/Forward Earnings ratio of 16.23.
HMSB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HMSB is cheaper than 62.75% of the companies in the same industry.
HMSB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.39
Fwd PE 16.23
HMSB.DE Price Earnings VS Forward Price EarningsHMSB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HMSB is valued a bit cheaper than 66.67% of the companies in the same industry.
HMSB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HMSB is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.83
EV/EBITDA 6.57
HMSB.DE Per share dataHMSB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HMSB may justify a higher PE ratio.
PEG (NY)2.76
PEG (5Y)N/A
EPS Next 2Y8.98%
EPS Next 3Y8.11%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.82%, HMSB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.63, HMSB pays a better dividend. On top of this HMSB pays more dividend than 92.16% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, HMSB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.82%

5.2 History

The dividend of HMSB decreases each year by -7.85%.
Dividend Growth(5Y)-7.85%
Div Incr Years0
Div Non Decr Years3
HMSB.DE Yearly Dividends per shareHMSB.DE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

95.04% of the earnings are spent on dividend by HMSB. This is not a sustainable payout ratio.
DP95.04%
EPS Next 2Y8.98%
EPS Next 3Y8.11%
HMSB.DE Yearly Income VS Free CF VS DividendHMSB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B
HMSB.DE Dividend Payout.HMSB.DE Dividend Payout, showing the Payout Ratio.HMSB.DE Dividend Payout.PayoutRetained Earnings

HENNES & MAURITZ AB-B SHS

FRA:HMSB (5/23/2025, 7:00:00 PM)

12.845

+0.02 (+0.16%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-27 2025-03-27/bmo
Earnings (Next)06-26 2025-06-26/bmo
Inst Owners22.84%
Inst Owner ChangeN/A
Ins Owners0.87%
Ins Owner ChangeN/A
Market Cap18.19B
Analysts51.67
Price Target14.08 (9.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.82%
Yearly Dividend0.6
Dividend Growth(5Y)-7.85%
DP95.04%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.38%
Min EPS beat(2)-46.79%
Max EPS beat(2)6.03%
EPS beat(4)1
Avg EPS beat(4)-18.19%
Min EPS beat(4)-46.79%
Max EPS beat(4)6.03%
EPS beat(8)4
Avg EPS beat(8)-8.17%
EPS beat(12)6
Avg EPS beat(12)-8.44%
EPS beat(16)9
Avg EPS beat(16)-9.37%
Revenue beat(2)0
Avg Revenue beat(2)-3.42%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-2.88%
Revenue beat(4)0
Avg Revenue beat(4)-3.2%
Min Revenue beat(4)-3.95%
Max Revenue beat(4)-2.01%
Revenue beat(8)0
Avg Revenue beat(8)-2.47%
Revenue beat(12)0
Avg Revenue beat(12)-2.31%
Revenue beat(16)0
Avg Revenue beat(16)-2.24%
PT rev (1m)0.74%
PT rev (3m)-4.83%
EPS NQ rev (1m)-0.89%
EPS NQ rev (3m)-16.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.84%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-4.6%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE 20.39
Fwd PE 16.23
P/S 0.83
P/FCF 9.83
P/OCF 6.16
P/B 4.28
P/tB 5.25
EV/EBITDA 6.57
EPS(TTM)0.63
EY4.9%
EPS(NY)0.79
Fwd EY6.16%
FCF(TTM)1.31
FCFY10.17%
OCF(TTM)2.08
OCFY16.23%
SpS15.39
BVpS3
TBVpS2.45
PEG (NY)2.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.18%
ROE 23.89%
ROCE 14.92%
ROIC 10.59%
ROICexc 12.41%
ROICexgc 13.6%
OM 7.17%
PM (TTM) 4.66%
GM 52.87%
FCFM 8.49%
ROA(3y)4.41%
ROA(5y)4.01%
ROE(3y)16.88%
ROE(5y)14.25%
ROIC(3y)7.98%
ROIC(5y)6.98%
ROICexc(3y)9.84%
ROICexc(5y)8.7%
ROICexgc(3y)10.94%
ROICexgc(5y)9.68%
ROCE(3y)11.28%
ROCE(5y)9.86%
ROICexcg growth 3Y2.73%
ROICexcg growth 5Y-9.12%
ROICexc growth 3Y3.25%
ROICexc growth 5Y-7.29%
OM growth 3Y-0.56%
OM growth 5Y0.23%
PM growth 3Y-3.61%
PM growth 5Y-3.01%
GM growth 3Y0.42%
GM growth 5Y0.31%
F-Score6
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF 3.87
Debt/EBITDA 1.64
Cap/Depr 53.43%
Cap/Sales 5.06%
Interest Coverage 25.29
Cash Conversion 81.44%
Profit Quality 182.17%
Current Ratio 1.15
Quick Ratio 0.51
Altman-Z N/A
F-Score6
WACC5.26%
ROIC/WACC2.01
Cap/Depr(3y)39.04%
Cap/Depr(5y)30.46%
Cap/Sales(3y)3.79%
Cap/Sales(5y)3.17%
Profit Quality(3y)328.53%
Profit Quality(5y)606.52%
High Growth Momentum
Growth
EPS 1Y (TTM)18.34%
EPS 3Y2.83%
EPS 5Y-2.32%
EPS Q2Q%-50.67%
EPS Next Y7.38%
EPS Next 2Y8.98%
EPS Next 3Y8.11%
EPS Next 5Y6.69%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y5.63%
Revenue growth 5Y0.15%
Sales Q2Q%3.1%
Revenue Next Year0.16%
Revenue Next 2Y1.28%
Revenue Next 3Y1.81%
Revenue Next 5Y1.02%
EBIT growth 1Y6.19%
EBIT growth 3Y5.03%
EBIT growth 5Y0.38%
EBIT Next Year125.36%
EBIT Next 3Y35.98%
EBIT Next 5Y21.37%
FCF growth 1Y3.37%
FCF growth 3Y-20.98%
FCF growth 5Y1.72%
OCF growth 1Y22.53%
OCF growth 3Y-10.72%
OCF growth 5Y1.84%